Indoco Remedies IPO GMP History
Indoco Remedies IPO has been listed on January 14, 2005 at a listing price of ₹401.55, against the issue price of ₹245 — a gain of ₹156.55 (+63.9%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Indoco Remedies IPO raised ₹73.5 Cr. through its IPO at a price band of ₹220 to ₹245 per share, with a lot size of 25 shares. The IPO was open for subscription from 17 Dec 2004 to 23 Dec 2004.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 8:58 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Indoco Remedies IPO dates
Key dates from opening to listing. Today is 12 November.
- Open 17 Dec 2004
- Close 23 Dec 2004
- Allotment 05 Jan 2005
- Refund/credit TBA
- Listing 14 Jan 2005
Indoco Remedies IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹245 |
|---|---|
| Listing gain / loss | +₹156.55 per share |
| Listing date | 14 Jan, 2005 |
| Actual listing price | ₹401.55 (+63.9%) |
Is Indoco Remedies IPO GMP reliable?
Grey market premium for Indoco Remedies IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Indoco Remedies IPO full review for a fundamentals-based assessment before making any grey market trades.
Indoco Remedies IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Indoco Remedies IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Indoco Remedies IPO
Indoco Remedies Limited was incorporated on 23 August 1947 as a public company. Its promoters are Suresh G. Kare, Aruna S. Kare, Aditi Kare Panandikar, Madhura A. Ramani and Shanteri Investment Private Limited.
It makes and markets branded pharmaceutical formulations in India.
Its brands include Sensodent-KF, which had grown into a Rs 3.10 crore brand as per ORG data for the year to July 2004, and cough and cold brands Febrex Plus and Tuspel Plus. It had 60 trademark registrations and 140 trademark applications pending.
The IPO was Rs 73.5 crore and was entirely a fresh issue at Rs 245, the top of the Rs 220 to Rs 245 band, with a face value of Rs 10.
Frequently asked
What is the GMP of Indoco Remedies IPO?
The current Grey Market Premium (GMP) of Indoco Remedies IPO is not yet started or active in the market.
What is the Kostak Price of Indoco Remedies IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Indoco Remedies IPO is not available.
What is the Subject to Sauda Price of Indoco Remedies IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Indoco Remedies IPO?
Indoco Remedies IPO listed on January 14, 2005 at ₹401.55, against the issue price of ₹245 — a gain of +63.9%.
How did the GMP of Indoco Remedies IPO trend before listing?
The GMP of Indoco Remedies IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Indoco Remedies IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
